07:36

Peter Bonis, MD

08:28

Susan DiGregorio

11:45

Michael Haydock

00:14

Candy Slide for a Safe Halloween

01:08:15

2020 Next-Generation Pharmacist Awards Ceremony

59:07

Pharmacy Times Webcast: Women Pharmacist Day

04:44

PT CLL DIOS Seg01 NCCN

02:51

PT CLL DIOS Seg02 Front

04:56

PT CLL DIOS Seg03 Limited

03:09

PT CLL DIOS Seg04 Newly

05:21

PT CLL DIOS Seg05 Develope

04:47

PT CLL DIOS Seg06 Naive

07:18

PT CLL DIOS Seg07 BTK

07:50

PT CLL DIOS Seg08 Oral

07:58

PT CLL DIOS Seg09 Adverse

04:38

PT CLL DIOS Seg10 Intravenous

08:21

PT CLL DIOS Seg11 Pharmacy

07:01

PT CLL DIOS Seg12 Community

01:12

Teaser

00:48

Improving Safety with IV Robotics

01:15

Utilizing IV Robotics in Hospital Pharmacy

01:11

Implementing IV Robotics in Hospital Pharmacy

01:17

Things to Consider When Implementing IV Robotics

00:48

Technological Solutions to the Opioid Epidemic

00:57

In-Home Adherence Technology

01:02

How Novel Technology Improves Patient Lives

05:35

COVID 19 Preparedness

03:15

week of 2 24

03:24

week of 2 18

03:08

February 14 Pharmacy Week in Review

03:16

week 2 2

03:14

week of 1 30

03:32

week of 1 22

03:14

week of 1 15

03:35

week of 1 8

03:51

week of 1 2

03:58

week of 12 17

02:31

Year in Review 2019

04:50

week of 12 11

03:54

week of 12 11

01:14

Novel Therapeutic Approaches in the CLL Treatment Pipeline

01:42

ASH 2019: New CLL Data Show Sustained Efficacy with Combo Targeted Therapies

01:19

Using Patient-Specific Factors to Guide Treatment Decisions in CLL

01:42

Ongoing CLL Trials Most Likely to Change Clinical Practice

01:22

An Overview of Adverse Effect Profiles for Current Targeted CLL Therapies

03:18

Week in Review 11/29

04:36

Week in Review 10/31

03:29

week of 10 20

02:10

Emerging Treatment Strategies in Advanced Pancreatic Cancer

03:58

week of 10 14

00:52

Provider Collaboration Prevents Medication Errors in the Oncology Setting

04:10

October 11 Week in Review

04:36

Pharmacy Week in Review 10/4

00:43

Clinical Implications of New Survival, Durability Data for Larotrectnib

00:34

Challenges in Treating TRK Fusion Cancer

00:28

Precision Medicine in Oncology: Strategies for Identifying Patients Needed

01:06

Positive Larotrectinib Data for TRK Fusion Cancer Presented at ESMO

00:58

Data on PARP Inhibitor Treatment in Ovarian Cancer Presented at ESMO

02:42

An Overview of the Ovarian Cancer Treatment Landscape

00:45

Considerations for Oncology Pharmacists Managing Patients on PARP Inhibitors